Objective. Degeneration of articular cartilage is central to the pathology of osteoarthritis (OA). However, the molecular mechanisms leading to these irreversible changes are still poorly understood. This study was undertaken to investigate how changes in the chondrocyte translational apparatus may contribute to the development and progression of knee OA.
Objective. Degeneration of articular cartilage is central to the pathology of osteoarthritis (OA). However, the molecular mechanisms leading to these irreversible changes are still poorly understood. This study was undertaken to investigate how changes in the chondrocyte translational apparatus may contribute to the development and progression of knee OA.
Methods. Articular cartilage from the knees of normal healthy subjects and patients with OA was used to analyze the activity of different components of the translational machinery. Chondrocytes isolated from lesional and nonlesional areas of the human OA cartilage were used to estimate the relative rate of protein synthesis by metabolic labeling. Experimental OA was induced by transection of the anterior cruciate ligament of rats to investigate changes in the translational apparatus associated with OA. The role of interleukin-1b (IL1b) signaling was assessed in vitro using rat articular chondrocytes. In human or rodent knee cartilage, messenger RNA expression was analyzed by quantitative polymerase chain reaction, and protein levels were determined by immunohistochemistry and Western blotting.
Results. Several novel traits of OA chondrocytes were identified, including up-regulation of the serine/ threonine kinases Akt-2 and Akt-3 at the posttranscriptional level and an increased rate of total protein synthesis, likely attributable to inactivation of eukaryotic initiation factor 4E binding protein 1 (4E-BP1), a known repressor of cap-dependent translation. Inactivation of 4E-BP1 was dependent on the activity of mechanistic target of rapamycin and was crucial for the up-regulation of protein synthesis in general and expression of matrix metalloproteinase 13 and ADAMTS-5 in particular. In addition, treatment of articular chondrocytes with IL-1b led to inactivation of 4E-BP1 and up-regulation of protein synthesis.
Conclusion. Precise control of protein synthesis is vital for cartilage homeostasis, and its dysregulation contributes to the molecular pathology of OA. The results of this study therefore identify a novel set of potential therapeutic targets to ameliorate the effects of knee OA.
Osteoarthritis (OA) is one of the most prevalent chronic diseases, but the mechanisms leading to OA are still not well understood. However, it is well accepted that degeneration of the articular cartilage is a hallmark of OA (1, 2) . Recently, several groups of investigators have shown the importance of proper regulation of mechanistic target of rapamycin (mTOR) kinase for cartilage homeostasis, and the role of mTOR in autophagy has been investigated in great detail in articular chondrocytes (3) (4) (5) (6) (7) (8) . However, protein synthesis, a vital cell function controlled by mTOR signaling, has not been investigated as a pathophysiologic mechanism in OA. We therefore studied how the translational machinery is modulated to facilitate changes in the expression of established OA-associated catabolic and anabolic mediators.
Protein synthesis is a very complex process that proceeds through initiation, elongation, and termination. Regulation of translation is a crucial component of gene expression control and is executed mostly at the initiation step (9) , during which the small ribosomal subunit, bound to several translation-initiation factors and the initiator methionyl-tRNAi, is recruited to messenger RNA (mRNA). Ribosomal loading onto mRNAs is mediated by eukaryotic initiation factor 4F (eIF4F), a protein complex consisting of eIF4A, eIF4G, and eIF4E (a cap-binding protein). By binding to the cap structure of mRNAs, eIF4E facilitates binding of the ribosomal complexes onto the mRNA 5 0 end and promotes protein synthesis (10) . One of the key mechanisms of translation regulation is modulation of eIF4E activity by eIF4E binding proteins (4E-BPs). There are 3 4E-BP isoforms, with 4E-BP1 being the most abundant one. The 4E-BP1 isoform acts as a repressor of cap-dependent translation by sequestering eIF4E from the active eIF4F complexes. The ability of 4E-BP1 to bind eIF4E is restricted by 4E-BP1 phosphorylation, as the hyperphosphorylated form is unable to bind eIF4E (11) . Phosphorylation and inactivation of 4E-BP1 is mediated by mTOR complex 1 (mTORC1), comprising the core components mTOR kinase, Raptor, and G protein b subunit-like protein (12) .
In this study, we found that OA cartilage has accelerated protein synthesis as a result of mTORC1-dependent 4E-BP1 inactivation, mediated by Akt signaling. Using an animal model of OA, we determined that changes in the activity of the chondrocyte translational apparatus are prominent at early stages of the disease and persist to later stages. Importantly, we found that modulation of 4E-BP1 activity in OA-like chondrocytes is correlated with the rate of protein synthesis in general, and 4E-BP1 inactivation is required not only for efficient translation of extracellular matrix (ECM)-degrading enzymes, such as matrix metalloproteinase 13 (MMP-13) and ADAMTS-5, but also for their transcription. We showed that interleukin-1b (IL-1b) signaling, with a possible synergistic effect of other cytokines, is largely responsible for 4E-BP1 inactivation and upregulation of protein synthesis in chondrocytes. Inhibition of the activity or expression of mTORC1 components in IL-1b-treated rat articular chondrocytes not only diminished up-regulation of ECM-degrading enzymes, but also annulled the cytokine effect on protein synthesis.
MATERIALS AND METHODS
Procurement of human knee cartilage. Samples of normal human knee cartilage (obtained from deceased subjects) were procured from the National Disease Research Interchange. Samples of OA knee cartilage were obtained from patients with advanced OA who had undergone knee replacement surgery. The surgically discarded specimens of human OA tissue were collected under the guidelines of the Institutional Review Board of New York University School of Medicine. Total protein was extracted from the cartilage in a manner as previously described (13) .
Isolation of human chondrocytes. Chondrocytes were isolated from the human knee cartilage as described previously (13) . Briefly, cartilage was dissected away from the subchondral bone and digested with Pronase (Sigma-Aldrich) for 1 hour at 378C, followed by overnight digestion with collagenase P (Roche Diagnostics) at 378C. Cells were cultured in highdensity monolayers.
Microarray analysis of human chondrocytes. Microarray analysis of the human articular chondrocytes was done in a manner as previously described (14) .
Experimental OA in a rodent model. All animal experiments were performed in accordance with the regulations of the Institutional Animal Care and Use Committee at New York University School of Medicine. Experimental OA was induced in 12-week-old male Sprague-Dawley rats by transection of the anterior cruciate ligament (ACLT) in the right knee, as described previously (15) .
Isolation and culture of rat articular chondrocytes. Articular cartilage was harvested from 12-15-week-old SpragueDawley rats for cytokine treatments and at 12 weeks and 20 weeks postsurgery. Cartilage slices were incubated for 90 minutes at 378C with 1% Pronase (weight/volume) and then for 2 hours at 378C with 0.4% (w/v) collagenase B (Sigma-Aldrich) in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal bovine serum (FBS), followed by incubation in DMEM supplemented with 5% FBS. Once the cells had reached confluence, they were starved for 16 hours and treated with 10 ng/ml of IL-1b in the presence or absence of 10 ng/ml of oncostatin M (OSM) or 100 ng/ml insulin-like growth factor 1 (IGF-1). For the inhibitor experiments, cells were pretreated with DMSO, Ku-063794 (1 mM), or phosphatidylinositol 3-kinase (PI3K) inhibitor IV (10 mM) for 1 hour, and then treated with IL-1b.
Transfections with mTOR small interfering RNA (siRNA) (nt2381; Sigma) were performed using Lipofectamine RNAiMax in accordance with the manufacturer's protocol; MISSION Universal siRNA was used as a negative control. Cells were starved for 16 hours in serum-free medium 24 hours posttransfection, and then treated with IL-1b.
To obtain 4E-BP-depleted cells, primers targeting the 4E-BP1 coding region (nt 382-404) were cloned into the pLKO.1 vector between the Age I and Eco RI sites, in accordance with the Addgene protocol. Lentiviruses were produced using 293T cells. Scrambled short hairpin RNA (shRNA) was used as a negative control.
Reverse transcription-quantitative polymerase chain reaction (qPCR) analyses. Immediately after digestion with collagenase B, RNA was extracted from the cultured rat articular chondrocytes or from cartilage isolated from the knees of rats, using an RNeasy Mini Kit (Life Technologies) in accordance with the manufacturer's protocol. Thereafter, 500 ng of total RNA was used for complementary DNA (cDNA) synthesis with an iScript cDNA synthesis kit (Bio-Rad). Quantitative PCR was run in a MyiQ Single-Color Real-Time PCR Detection System (Bio-Rad) using iQ SYBR Green Supermix. Relative gene expression levels were calculated using the DDC t method. Target mRNA levels were normalized to the values for 18S ribosomal RNA (the primers used in qPCR analyses are listed in Supplementary Tables 1 and 2 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley. com/doi/10.1002/art.39947/abstract).
Immunohistochemical analyses. Immunohistochemical analysis of human cartilage samples was performed as described previously (14) . For immunohistochemical analysis of the rat articular cartilage, the knee joints from ACLT-operated rats (n 5 5) and sham-operated rats (n 5 5) were harvested and fixed in 4% paraformaldehyde for 24 hours and then decalcified in Formical2000 (Decal Chemical) for 96 hours, followed by paraffin embedding. Serial sections (4 mm) were stained with toluidine blue and examined for histopathologic changes, using a semiquantitative scoring system (a list of the antibodies used in immunohistochemistry is shown in Supplementary Table 3, http://onlinelibrary.wiley.com/doi/10.1002/art.39947/abstract). For antigen retrieval, sections were incubated with proteinase K for 7 minutes at 378C, followed by incubation with Triton X-100 for 15 minutes. An avidin-biotin-peroxidase system (Vector) was used, and antigen-antibody complexes were visualized using diaminobenzidine as substrate. Tissue samples were counterstained with hematoxylin.
Metabolic 35 S labeling. To analyze the rate of total protein synthesis, an equal number of cells was used within each condition tested (100,000 cells per condition). A 35 S incorporation assay was carried out as previously described (16) .
Analysis of MMP-13 activity. MMP-13 activity was analyzed using the Fluorokine E kit (R&D Systems) in accordance with the manufacturer's instructions. When 35 S labeling was performed, supernatants were collected just prior to labeling.
Statistical analysis. Results are expressed as the mean 6 SD. GraphPad Prism software version 6.0 (http:// www.graphpad.com) was used for statistical analysis, and the level of significance was set at 0.05. More specifically, Student's paired t-tests were performed for comparison of lesional and nonlesional samples, for the quantification of samples showing positive immunohistochemical staining, and for comparison of 2 sets of data from the rat articular chondrocytes. In other cases, a one-way analysis of variance was performed, with Bonferroni correction for multiple comparisons. A one-sample t-test was performed for the 35 S incorporation experiments, comparing the median value to the hypothetical value of 1, which is the value that was set for the untreated controls or sham-treated animals.
RESULTS
Increased rate of total protein synthesis accompanying aberrant activity and expression of components of the translational machinery in human OA cartilage. Expression of mRNA for components of the eIF4F complexes (eIF4G, eIF4A, and eIF4E) was examined in human OA cartilage, as well as in non-OA cartilage samples as normal controls, using Affymetrix U133A microarray data. Results of the microarray analysis revealed that eIF4GII was significantly up-regulated in diseased tissue (P 5 0.0051 versus normal controls) ( Figure 1A) , with no significant changes in the expression of eIF4A and eIF4E (results in Supplementary Figure 1A , available on the Arthritis & Rheumatology web site at http:// onlinelibrary.wiley.com/doi/10.1002/art.39947/abstract). These microarray data were further validated by qPCR analysis of individual cartilage samples ( Figure 1A and Supplementary Figure 1A) .
Up-regulation of eIF4G expression suggests that OA cartilage has a higher capacity for accelerated protein synthesis, which likely has an essential impact on the higher rates of cell turnover observed in OA tissue. We therefore performed immunoblotting analyses to analyze the abundance and activity of known effectors of protein synthesis, such as 4E-BP1, and components of the Akt/ mTOR pathway. To analyze changes in eIF4F activation, we used eIF4E as a loading control, since we have previously detected no changes in eIF4E mRNA levels in OA cartilage; this loading control consistently yielded immunoblot findings similar to those produced by a-actin in all of the samples analyzed ( Figure 1C ). As shown in Figure1A, there were no changes in total 4E-BP1 levels in OA cartilage relative to non-OA normal controls. However, we detected an ;3-fold increase in expression of the hyperphosphorylated (Ser 65 -positive) form of 4E-BP1 in OA cartilage. Four known phosphorylation sites modulate 4E-BP1 activity: Thr 37 and Thr 46 are phosphorylated first, followed by Thr 70 and Ser
65
. Phosphorylation of Ser 65 by mTORC1 complexes precludes eIF4E binding and, thus, inactivates 4E-BP1 (17) . Therefore, our data indicate that the proportion of inactive 4E-BP1 is higher in OA cartilage than in normal tissue.
In addition, articular cartilage samples from OA patients had higher protein and mRNA levels of MMP-13 and ADAMTS-5 compared to articular cartilage from normal controls ( Figure 1A and Supplementary Figure 1A) . These findings are consistent with the well-established role of MMP-13 and ADAMTS-5 in the pathogenesis of OA (18, 19) .
It is known that 4E-BP1 is a direct target of mTORC1, a process that has recently been implicated in autophagy defects in OA cartilage. Moreover, elevated mTOR mRNA levels have been found in human OA cartilage (3, 20, 21) . We therefore characterized mTOR activity by using phospho-specific antibodies to p70S6K, its direct downstream target. As shown in Figure 1A , p70 S6 kinase (p70S6K) was robustly phosphorylated in human OA samples. However, no significant changes in the expression levels of p70S6K mRNA or mTOR mRNA were detected in OA samples, either by microarray analysis or by qPCR analysis (see Supplementary Figure 1A) .
We next examined the phosphorylation status of Akt, a positive regulator of mTORC1, in cartilage samples from OA patients. Akt is activated by phospholipid binding and by phosphorylation on Thr 308 and Ser 473 (22) ; therefore, Ser 473 phosphorylation is commonly used as an indirect readout of Akt activity. As shown in Figure 1A , Akt (Ser 473 ) was present nearly exclusively in OA samples, thus showing that increased mTOR activity is correlated with Akt (Ser 473 ) phosphorylation. Surprisingly, although the protein levels of Akt-2 and Akt-3 were up-regulated in OA cartilage, their mRNA levels 588 KATSARA ET AL were not increased ( Figure 1A ). These data are the first to suggest that regulation of the expression of Akt-2 and Akt-3 at the posttranscriptional level might contribute to its increased phosphorylation and activity in OA cartilage.
To further validate our data, we analyzed lesional and nonlesional areas of knee OA cartilage from the same patient, using 4E-BP1 (Ser 65 ) antibodies in immunohistochemical analyses. Both areas were located on the medial compartment, within the closest possible proximity. Although this approach has some limitations (since nonlesional areas are not truly representative of non-OA cartilage), our analysis revealed that ;80% of the cells stained positive for 4E-BP1 in lesional areas, as compared to ;5% in nonlesional areas ( Figure 1B We next compared the rate of total protein synthesis in cells from lesional and nonlesional areas of OA cartilage obtained from 4 patients who had undergone total knee replacement. Total protein synthesis was measured by pulse-labeling with 35 S-Met/Cys. As shown in Figure  1D , chondrocytes isolated from lesional areas incorporated 30-40% more 35 S-Met/Cys than did chondrocytes from nonlesional areas, thereby validating our hypothesis that inactivation of 4E-BP1 leads to up-regulation of translation in OA chondrocytes. Because the lesional and nonlesional samples were obtained from the joints of OA patients who had end-stage disease, it is possible that the changes in translational apparatus in advanced medial compartment knee OA tissue may not only represent direct effects of the disease, but also indicate the effects of altered mechanical loading.
Increased rate of total protein synthesis after surgical induction of OA in rat articular cartilage. Since we observed increased activity of the translational apparatus in human OA cartilage, we further corroborated these findings using an ACLT model of surgically induced (posttraumatic) OA in rats (15) . Articular cartilage harvested from ACLT-operated animals was analyzed for the mRNA expression levels of Mmp13, Adamts5, the type II collagen a1 gene (Col2a1), and the gene for aggrecan (Acan) (results in Supplementary Figure  2A Results are the mean 6 SD of 4 independent experiments, normalized to total cell number. * 5 P # 0.05; *** 5 P # 0.001; **** 5 P # 0.0001, by unpaired t-test. NS 5 not significant (see Figure 1 for other definitions).
confirmed the increased expression of MMP-13 and MMP-3 within the ACLT-operated joints compared to sham-operated joints (Figure 2A ). Although MMP-13 localization was observed most predominantly at 12 weeks postsurgery (consistent with the findings in other animal models [23, 24] ), prominent staining of matrixassociated MMP-13 was also detected at 20 weeks postsurgery. Increased MMP-13 expression was correlated with its catalytic activity in the ACLT-operated joints, since the amount of active enzyme was significantly higher in rats with ACLT-operated joints compared to rats with sham-operated joints ( Figure 2C ). Consistent with the data from human OA cartilage, immunohistochemical analysis of phospho-p70S6K, a direct mTORC1 target, and 4E-BP1 (Ser 65 ) indicated that mTOR activity was increased in the knee cartilage from rats with experimentally induced OA compared to cartilage from rats with sham-operated joints ( Figure  2A) . Remarkably, 4E-BP (Ser 65 )-positive cells showed similar levels of increase in mTOR activity both at 12 weeks postsurgery and at 20 weeks postsurgery, indicating that the proportion of inactive 4E-BP peaks as early as 12 weeks after ACLT. We obtained similar results when rat articular chondrocytes were analyzed in immunoblotting analyses, comparing chondrocytes from ACLT-operated joints and those from sham-operated joints ( Figure 2B ).
We also characterized the phosphorylation of a direct Akt target, proline-rich Akt substrate of 40 kd (PRAS40) (25) , and the results were consistent with those in our analysis of Akt (Ser 473 ) phosphorylation. Chondrocytes isolated from ACLT-operated joints at both 12 weeks and 20 weeks postsurgery incorporated more 35 S-Meth/Cys than did chondrocytes from sham-operated control joints ( Figure 2D ), indicating that the rate of total protein synthesis is higher in OA cartilage. Thus, our data showed that up-regulation of mTOR signaling leads to inactivation of 4E-BP1 and correlates with an increased rate of protein synthesis in both human OA cartilage and a rodent model of posttraumatic OA. We also observed changes in the expression of autophagy genes affected by mTOR signaling (results in Supplementary Figure 2B , http://onlinelibrary.wiley.com/doi/10. 1002/art.39947/abstract), as was previously reported (4).
IL-1b-mediated changes leading to accelerated protein synthesis. Among the many proinflammatory cytokines implicated in OA pathology (26) , IL-1b has a prominent role (27) . IL-1b treatment is routinely used to model OA-like changes in in vitro studies. We therefore adopted this system to investigate the changes in the chondrocyte translational machinery. We recognize the many limitations of this technique and, therefore, do not consider it to be a model of OA itself, but rather an OA-like system, which can help to decipher the complexity of this chronic, multifactorial disease.
Consistent with the findings of previous studies, IL-1b treatment of articular chondrocytes from 12-weekold rats resulted in activation of MAPKs (ERK, p38, and JNK) and up-regulation of mRNA and protein expression of cartilage-specific targets (results in Supplementary  Figures 3A, B , and D, available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10. 1002/art.39947/abstract) (28, 29) , as well as increased expression and activity of MMP-13 ( Figure 3B ). We also observed activation of the Akt/mTOR pathway and increased phosphorylation of 4E-BP1 and p70S6K during IL-1b treatment ( Figure 3A) . Importantly, total protein synthesis was increased as early as 6 hours after the initiation of IL-1b treatment ( Figure 3B ), implying that IL-1b signaling might be responsible for the higher translation rates observed in OA chondrocytes.
We next investigated whether inclusion of an additional cytokine would have either a cumulative effect or a synergetic effect on protein synthesis. We chose the cytokine OSM, because its expression is elevated in OA cartilage and it also stimulates the STAT-3 pathway (as shown in Supplementary Figure 3C , http://onlinelibrary. wiley.com/doi/10.1002/art.39947/abstract) (28, 30) . Akt (Ser 473 ) phosphorylation was more robust when chondrocytes were treated with both cytokines than upon treatment with IL-1b alone ( Figure 3C ). There were no significant changes in the expression of Mmp13 and Adamts5 mRNA upon combined treatment (results in Supplementary Figure 3E , http://onlinelibrary.wiley.com/ doi/10.1002/art.39947/abstract), and MMP-13 activity did not change either with combined treatment or with IL-1b alone ( Figure 3D ). When the total protein synthesis rate was compared between cells treated with both cytokines and cells treated with IL-1b alone, the rate was found to be similar in both treatment groups ( Figure 3D ). These data highlight IL-1b signaling as one of the main modulations of the translational machinery in OA-like chondrocytes.
Subsequently, we investigated whether the changes in translational machinery induced by IL-1b treatment were comparable to those obtained by stimulation of chondrocyte proliferation by anabolic factors such as ) and PRAS40 were phosphorylated more robustly by IGF-1 than by IL-1b. Although we observed an increase in 35 S incorporation upon IGF-1 treatment (Figure 4C ), this stimulation had no effect on the mRNA and protein levels of ECM-degrading enzymes in rat articular chondrocytes ( Figure 4B ; see also Supplementary Figure 4 , available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.39947/abstract). Clearly, IL-1b signaling provides a favorable environment for both mRNA and protein expression of genes implicated in the pathogenesis and progression of OA, even if the increased rate of total protein synthesis is more modest.
Effect of expression of dominant-negative (DN) 4E-BP1 on the levels of ECM-degrading enzymes and total protein synthesis in IL-1b-treated rat articular chondrocytes. The changes in 4E-BP1 phosphorylation observed in chondrocytes from rats with experimentally induced OA prompted us to examine its potential role in the regulation of the expression of ECM-degrading enzymes. For this purpose, we used 4E-BP1 mutants that have been characterized previously (17) . The 4E-BP1 AA mutant (DN 4E-BP1) has substitutions of Thr 37 and Thr 46 to Ala, and therefore cannot be phosphorylated or inactivated. The 4E-BP1 AADE mutant has the same mutations as the AA mutant but also has deletion of the eIF4E binding domain, and therefore cannot act as a DN mutant.
Tranfection of rat articular chondrocytes with DN 4E-BP1 blocked the IL-1b-induced up-regulation of Mmp13, Adamts5, and Mmp3 mRNA. In contrast, transfection of the wild-type 4E-BP1 or the 4E-BP1 AADE mutant had no significant effects ( Figure 5A ; see also Supplementary Figure 5A , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/doi/10.1002/ art.39947/abstract). This effect was reflected at the protein level as well, with ADAMTS-5 being surprisingly the most sensitive to expression of the DN mutant in rat articular chondrocytes.
Crucially, the IL-1b-induced up-regulation of total protein synthesis was suppressed by the expression of DN 4E-BP1, but not by its deletion mutant version ( Figure 5B ). These data indicate that inactivation of 4E-BP1 is crucial for up-regulation of total protein synthesis in general, and in particular, for the expression of ECM-degrading enzymes.
We next examined whether down-regulation of 4E-BP1, which mimics its inactivation, would have an opposite effect. Rat articular chondrocytes were infected with a lentiviral vector expressing a scrambled control short hairpin RNA (shRNA) or a 4E-BP1 shRNA ( Figure   5C ). Cells expressing 4E-BP1 shRNA showed stronger expression of Mmp13 and Adamts5 mRNA upon IL-1b stimulation as compared to cells expressing scrambled control shRNA, with nonsignificant changes in the expression of Mmp3, Acan, and Col2a1 mRNA ( Figure 5C ; see also Supplementary Figures 5B and C, http://onlinelibrary. wiley.com/doi/10.1002/art.39947/abstract). Thus, these experiments established the importance of 4E-BP1 inactivation in the up-regulation of protein synthesis and efficient expression of MMP-13 and ADAMTS-5 in OA-like chondrocytes (Figures 5A-D) .
Crucial role of mTOR kinase activation in the up-regulation of protein synthesis by IL-1b. We next determined the mechanism by which mTOR mediates the inhibition of IL-1b-induced up-regulation of translation in Figure 6 . Activity of mechanistic target of rapamycin complex 1 (mTORC1) is crucial for interleukin-1b (IL-1b)-induced changes in the translational machinery. A, Rat articular chondrocytes were pretreated (for 1 hour) with DMSO, phosphatidylinositol 3-kinase IV inhibitor (PI3Kin) (10 mM), or Ku-0063794 inhibitor (1 mM). Left, Immunoblots showing activation of proteins of the Akt/mTOR pathway in rat articular chondrocytes after the indicated pretreatments and with or without 30 minutes of IL-1b treatment (a-actin serving as the loading control). Middle and right, Fold change in expression of matrix metalloproteinase 13 (MMP-13) and ADAMTS-5 mRNA (values normalized to those for 18S ribosomal RNA) (middle) and in IL-1b-mediated total protein synthesis (right) in pretreated rat articular chondrocytes. Values are the mean 6 SD of 3 independent experiments. B, Left and middle, Fold change in expression of MMP-13, MMP-3, and ADAMTS-5 mRNA (values normalized to those for 18S ribosomal RNA) was measured (left) and immunoblotting for mTOR and MMP-13 protein expression was performed (a-actin serving as a loading control) (middle) in rat articular chondrocytes treated with mTOR small interfering RNA (siRNA) or with negative (neg) control siRNA. Right, Fold change in protein synthesis in siRNA-treated rat articular chondrocytes following 24 hours of IL-1b treatment. Values are the mean 6 SD of 3 independent experiments. C, Specific down-regulation of mTORC1 complexes was assessed in rat articular chondrocytes using Raptor knockdown with short hairpin RNA (shRNA) targeting Raptor (shRaptor; shRptor) as compared to scrambled control shRNA (scr). Effects of down-regulation of Raptor expression were assessed as the fold change in MMP-13, MMP3, and ADAMTS-5 mRNA expression (values normalized to those for18S ribosomal RNA) after shRNA treatments (left panel), as well as the protein expression of MMP-13, MMP3, and ADAMTS-5 and the fold change in active MMP-13 expression and total protein synthesis after shRNA treatments and with or without IL-1b treatment (right panels). Values are the mean 6 SD of 3 independent experiments. * 5 P # 0.05. rat articular chondrocytes. Cells were pretreated with the mTOR kinase inhibitor Ku-063794 (31) or with PI3K inhibitor IV, and then stimulated with IL-1b. As shown in Figure 6A , mTOR inhibition led to complete loss of Akt (Ser   473   ) , rpS6, and 4E-BP1 (Ser 65 ) phosphorylation and to significant reductions in the expression of Mmp13 and Adamts5 mRNA. Moreover, protein synthesis was considerably suppressed in the presence of the Ku-063794 inhibitor ( Figure 6A) .
Finally, we examined whether down-regulation of mTOR or Raptor has similar effects. The down-regulation of mTOR by siRNA and the down-regulation of Raptor by shRNA decreased the stimulatory effects of IL-1b on the expression of Mmp13, Mmp3, and Adamts5 mRNA, with Mmp13 and Adamts5 being particularly sensitive to the down-regulation of Raptor, which likely could be attributed to mTORC1-specific inhibition (Figures 6B and C; see also Supplementary Figure 6 , available on the Arthritis & Rheumatology web site at http://onlinelibrary. wiley.com/doi/10.1002/art.39947/abstract). Thus, these results showed that the effect of IL-1b on protein synthesis in rat articular chondrocytes is largely mediated by mTORC1 signaling and requires inactivation of 4E-BP1, the repressor of cap-dependent translation. This mechanism (with some additional tiers and players) is likely utilized in OA chondrocytes to accelerate the rate of total protein synthesis.
DISCUSSION
Currently, there are no disease-modifying drugs to slow cartilage degeneration in OA, as the complex and heterogeneous nature of the disease complicates our understanding of the pathogenic mechanisms of OA. Therefore, it is extremely important to identify new potential targets for diagnosis and treatment of OA at the early stages of the disease. For this purpose, understanding the role of translational control mechanisms in OA progression is of particular importance, as it can allow us to modulate protein expression in a rapid and reversible way, when changes at the transcriptional level are irreversible.
The importance of translational control has become apparent, since correlations between changes at the mRNA and protein level are typically quite modest (32) and it is a challenge to identify correlations of welldescribed mRNA signatures for OA (33) (34) (35) with extensive proteomics data (36) . Clearly, posttranscriptional gene regulation must be taken into consideration in conjunction with changes in the levels of mRNA expression. For example, Tew and colleagues have shown that the number of mRNAs with shortened half-lives is significantly higher in OA samples (37) .
The results of the present study show that the rate of total protein synthesis is higher in human and rodent OA chondrocytes. Abnormal mTORC1 signaling resulting in reduced autophagy and increased cell death has been previously implicated in OA pathology (3, 20, 38) . These studies demonstrated that inhibition of mTOR activity, either by its cartilage-specific deletion or by rapamycin, protects mice from surgically induced OA. Although this inhibition restores autophagy, it also down-regulates the rate of total protein synthesis. Indeed, the rate of translation in IL-1b-treated chondrocytes is sensitive to mTORC1 inhibition (by siRNA, by Ku-063794, or by inhibition of Raptor expression), thus indicating that protein synthesis is an essential target of dysregulated mTORC1 signaling in OA cartilage. We established that in OA-like chondrocytes, up-regulation of translation is mediated by mTORC1 signaling and requires inactivation of 4E-BP1, its direct substrate. It would be interesting to assess the rate of total protein synthesis in an animal model of OA postoperatively using rapamycin-treated animals compared to untreated animals.
Remarkably, the percentage of 4E-BP1 (Ser 65 )-positive cells was similar at 12 weeks and at 20 weeks postsurgery, indicating that 4E-BP1 activation likely reaches its maximum as early as 12 weeks after ACLT, when the morphologic changes of the cartilage are still modest. We chose a later time point in this model in order to observe whether the changes would be similar to that seen in human OA cartilage, as up-regulation of protein synthesis in the ACLT model of OA at 20 weeks postsurgery was similar to that observed in chondrocytes from lesional areas compared to nonlesional areas of human OA cartilage. This finding, however, raises an important question with regard to what is the earliest time point during OA progression at which we could detect an increase in the activity of the translational machinery, a point that warrants further investigation.
Our data also show that another mTORC1 substrate, p70S6K, is activated in human OA cartilage, as well as in an animal model. Although we were not able to detect a significant increase in mTOR mRNA or protein expression in cartilage from patients with advanced OA, as has been reported previously (3, 21) , we consistently detected increased mTOR activity. The upregulation of Akt activity that we observed in OA cartilage is likely to be a key posttranslational effector of mTORC1 activity. We found that Akt isoforms are differentially expressed in human OA chondrocytes, and it would be interesting to investigate whether any changes in the expression/activation of these isoforms might occur during OA progression. PI3K/Akt signaling has been implicated in OA-like changes in vitro (28, 39) , and its importance in vivo is indirectly supported by the notion that expression of microRNA-634, a negative regulator of PI3K, is decreased in OA cartilage (40) .
We treated rat articular chondrocytes with IL-1b to mimic some changes observed in human OA chondrocytes. Although this system does not fully reflect the complexity of OA, the findings in our ACLT model corroborated those from our in vitro studies. We demonstrated that up-regulation of protein synthesis requires mTORC1 activity and 4E-BP1 inactivation. While the addition of OSM simultaneously with IL-1b had minimal effects on the translational apparatus, up-regulation of many age-related inflammatory cytokines should also be taken into account, as the expression of many of these cytokines, including leptin, might affect the translational machinery in a localized manner (41) .
Interestingly, the increase in the rate of total protein synthesis was comparable between 6 hours and 24 hours of IL-1b treatment, likely because it had reached its possible capacity. This level of up-regulation might be used differentially by mRNAs depending on their 5 0 -untranslated regions (5 0 -UTRs) and relative abundance. Clearly, this up-regulation is adequate to promote efficient translation of MMP-13, as the levels of Mmp13 mRNA increased gradually in rat articular chondrocytes.
The activation of the translational machinery in OA chondrocytes can serve several distinct purposes (see Supplementary Figure 7 , available on the Arthritis & Rheumatology web site at http://onlinelibrary.wiley.com/ doi/10.1002/art.39947/abstract). First, inactivation of 4E-BP1 acts as a double-edged sword to accommodate increased production of proteins and those mRNAs that are up-regulated in OA cartilage, such as matrix proteins and matrix-degrading enzymes. Second, inactivation of 4E-BP1, which results in a higher proportion of active eIF4F, might be crucial for the translation of particular mRNAs with long and structured 5 0 -UTRs, such as, for example, ADAMTS-5. This hypothesis is supported by the high sensitivity of ADAMTS-5 translation (not transcription) to 4E-BP activity and to inhibition by CHX (an inhibitor of protein synthesis) in IL-1b-simulated chondrocytes (see Supplementary Figure 5C , http:// onlinelibrary.wiley.com/doi/10.1002/art.39947/abstract). Another potential, yet unidentified, 4E-BP-sensitive target seems to be crucial for MMP-13 transcription, as Mmp13 mRNA levels were sensitive both to 4E-BP activity and to CHX treatment.
In conclusion, our data demonstrate the contributions of both translational and nontranslational effectors to chondrocyte homeostasis in patients with OA and in a rodent model of OA. These findings may offer a potential set of novel targets for OA therapy.
